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Background: Most of the knowledge about the mechanisms of multidrug resistance in lung cancer has been
achieved through the use of cell lines isolated from tumours cultivated either in suspensions of isolated cells or in
monolayers and following exposition to different cytostatic agents. However, tumour cell lines growing as
multicellular tumour spheroids (MTS) frequently develop multicellular resistance in a drug-independent form. The
aim of this study was to characterize the phenotypic and functional differences between two human NSCLC cell
lines (INER-37 and INER-51) grown as traditional monolayer cultures versus as MTS.
Methods: After 72 hours treatment with anticancer drugs, chemosensitivity in monolayers and tumour spheroids
cultures was assessed using MTT assay. Reverse transcription-polymerase chain reaction was employed to detect
the mRNAs of multidrug resistance-related genes. The expression of P-gp was analyzed by immunohistochemical
staining and cell cycle profiles were analyzed using FACS.
Results: The results indicate that when grown as MTS each lung cancer cell line had different morphologies as well
as and abrogation of cell proliferation with decrease of the G2/M phase. Also, MTS acquired multicellular resistance
to several chemotherapeutic agents in only a few days of culture which were accomplished by significant changes
in the expression of MDR-related genes.
Conclusion: Overall, the MTS culture changed the cellular response to drugs nevertheless each of the cell lines
studied seems to implement different mechanisms to acquire multicellular resistance.
Keywords: Multicellular tumour cancer spheroids, Multicellular resistance, Multidrug resistance genes, Drug
cytotoxicity, Three-dimensional culture, Lung cancerIntroduction
Lung cancer is the most common cause of cancer-
related deaths in the world, causing more than one mil-
lion deceases worldwide each year [1]. Despite of the
major advances in patient management, chemotherapy
and radiotherapy made over the past decades, long-term
survival is only obtained in 20-35% of the patients with
advanced non-small cell lung cancer [2,3], and even with
the use of new target therapies, the response has not
been as spectacular as expected [4].* Correspondence: barrerrarr@hotmail.com
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unless otherwise stated.The major obstacle in lung cancer treatment is the in-
trinsic resistance that these tumours present to chemo-
therapy [5]. As a result, much of what we know about
the mechanisms of multidrug resistance in lung cancer
has been obtained through the use of cell lines isolated
from tumours cultivated either in suspensions of isolated
cells or in monolayers (2D) and exposed to different cy-
tostatic agents [6]. However, monolayer cell cultures lack
the three-dimensional cell arrangement that may partici-
pate in the emergency of the drug-resistant phenotype.
To overcome these limitations, multicellular tumour spher-
oids (MTS) have been developed to reproduce in vitro the
histological and architectural organization of the tumour
tissue [7]. Interestingly, when tumour cells are cultured as
MTS, they spontaneously develop resistance to severalan Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cellular resistance" (MCR) [8,9]. Therefore, MTS appear
to be more resistant to drugs than monolayer cultures
[10] indicating that the multicellular tissue architecture
and the altered cell-cell contact may play a role in the
mechanism of MCR acquisition [11].
Several hypotheses have been proposed to explain the
acquisition of MCR. One is the development of non-
proliferating quiescent cells in central areas of the tumour,
characterized by extreme microenvironment conditions
and hypoxia [12,13]. A correlation between the appear-
ance of the quiescent cell subpopulation in large MTS and
P-glycoprotein (P-gp) mediated resistance has been sug-
gested [14]. However, the contribution of P-gp and the
other MDR-related gene products has not been exten-
sively analyzed yet.
Albeit, a great number of studies suggest that only one
cellular mechanism confers MCR, a few of them try to
explain the real contribution of different pathways in the
MTS cultures; even less studies are focused in lung can-
cer tumours. Therefore, we decided to grow human lung
cancer cell lines as MTS to analyze the changes in drug
sensibility as well as the molecular mechanisms that de-
velop to acquire MCR. Our results showed that the
MTS culture of two lung cancer cell lines induced MCR
to several chemotherapeutic drugs after only a few days
of culture. The MCR in lung cancer cell tumours was
accomplished by the generation of quiescent cells and
strong changes in the expression of MDR-related genes.
However to acquisition of MCR by each multicellular
tumour spheroid seems to depend on the specific nature
of each the cell line.
Results
As monolayers, both lung cancer cells showed different
growth patterns, with INER-37 cells growing as adherent
cells forming a proper monolayer and a doubling time of
79 hours, whereas INER-51 cells showed a loosely adher-
ent phenotype and a doubling time of 31 hours.
Histological appearance
When cultured in a non-adhesive environment, both
lung cancer cells can aggregate and differentiate into
MTS. Ultramicroscopic examination of MTS showed cell
aggregates with great compactness (Figure 1A and B).
However, by hematoxilin-eosin staining, both lung can-
cers MTS were formed by completely different struc-
tures. Thus, INER-37 spheroids were formed by small
aggregates with cells tightly attached to each other, while
reaching an approximately diameter of 550 ± 25 μm
(Figure 1C and E), whereas INER-51 spheroids were
formed by larger aggregates, which acquired a maximal
diameter of 1,314 ± 30 μm (Figure 1D and F). In INER-
51 MTS, two zones were clearly visible: the peripheralzone composed by a rim of tightly attached cells and the
inner zone where cells were more loosely attached
forming a lax tissue and showing multiple empty spaces.
During 72 hrs of spherule culture, evidence of necrotic
zones were not seen in either of the two MTS.
Monolayers and MTS proliferation
Several reports have mentioned that tumour cells grow-
ing as MTS have a significant impact in their prolifera-
tion rate. Thus, it was important to find out if under our
culture conditions, the cell proliferation was also al-
tered. The results showed a dramatic decrease in cell
proliferation when cells were cultured as MTS when
compared with cell lines grown as monolayer (Figure 2).
This decrease was evident as early as 24 hrs of culture
and was kept during the whole experimental period.
Cell cycle analyses
To determine whether the ending of cell growth in the
spheroid culture correspond to the cells arrest in a par-
ticular phase of the cell cycle, we analyzed a fraction of
DNA by flow cytometry. Figure 3 shows cytometric plots
of DNA for monolayers and MTS, showing cell cycle
distribution of the analysed cells. Interestingly, a consist-
ently higher proportion of cells were in G1 phase and a
significantly reduced amount of cells was at the G2/M
phase throughout the growth of the MTS as compared
to monolayer exponential phase. Thus, the population
on G2/M decreased in the MTS condition for both cell
lines: 19.5% (monolayer) vs 6.9% (spheroid) for INER-37
and 21.8% (monolayer) vs 10.4% (spheroid) for INER-51,
with a consequent change in the percentage of the cell
cycle phases.
Drug resistance profiles of monolayes and MTS
In order to know how the culture condition affected
drug response, both monolayers and MTS were exposed
to a panel of several chemotherapeutic drugs. In almost
all cases, MTS were significantly less sensitive than
monolayers to all drug concentrations tested. For ex-
ample, when INER-37 and INER-51 MTS were exposed
to 500 μM of etoposide, the survival rate was higher
than 90% and 73%, whereas in monolayers the survival
rate was 10% and 20% respectively (Figure 4). A similar
pattern was seen when MTS were exposed to teniposide,
camptothecin and doxorubicin with the survival rate
always higher than in monolayers. Interestingly, no
significant change the activity of cisplatin was found be-
tween MTS vs monolayer in two lung cancer cell lines.
A detailed contrast of IC50 values of MTS to several
cytotoxic agents is show in the Table 1. In all cases, the
increase in drug resistance was evident with IC50 values
being higher in MTS than in monolayers. On INER-51
MTS the relative resistance respect to monolayers was
Figure 1 INER-37 and INER-51 MTS morphology. Left panels correspond to INER-37 spheroids while right panels are INER-51 spheroids. Panels A
and B show an ultramicrographic photograph of the respective MTS after 72 hours of in vitro culture (200X). Panels C to F are different H&E
staining microphotographs of the MTS. For panels C and D, the amplification was 400X, and for E and F it was 1200X.
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intrinsically more sensitive to anticancer agents.
Drug resistance can be related to cell-interactions be-
cause cell lines arrested by serum deprivation showed
only a discrete increase in resistance to etoposide with
IC50 values of 45 μM and 26 μM in INER-37 and INER-
51 respectively, in contrast to higher resistance in multi-
cellular spheroids (data not shown).
Expression of MDR-1 and multidrug resistance associated
genes
With the aim of determining if MTS formation affected
the expression of genes associated with the acquisition
of resistance, we analysed several of them. RT-PCR
analysis shows different patterns of mRNA expression
for each MTS. Thus, INER-37 monolayers did not ex-
press MDR-1 gene but it was tuned-on when cells werecultured as MTS (Figure 5). For INER-51 cells, the ex-
pression of MDR-1 was equal and independent of the
culture conditions. Contrarily, MRP-1 expression was
up-regulated on INER-37 spheroids but in INER-51
cells, neither monolayers nor MTS expressed it. For
Topo IIα gene, INER-37 MTS did not show changes in
its expression but this gene was down-regulated in
INER-51 MTS. Furthermore, expression of Topo IIα on
INER-51 monolayer was less than in INER-37 cells. For
Topo IIβ gene, both MTS cell lines up-regulated its
expression. Other genes associated with drug resistance
were also analyzed. Thus, the GST-μ expression in
INER-37 was positive and independent from the culture,
but INER-51 cells did not express this gene under any
culture condition. In the case of Topo I, a similar ex-
pression was observed for the two cell lines, which was
independent of the culture conditions. The expression
Figure 2 Changes of growth patterns of human lung cancer cell
lines grown as monolayers (black symbols) or multicellular tumour
spheroids (white symbols). Increase in cell proliferation was
determinate by MTT assay every day. Data are mean ± standard
deviation (SD) of three independent experiments.
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scripts in all the experiments.Immunostaining of P-gp in INER-37 MTS
To verify if MDR-1 transcript on INER-37 MTS corre-
lated with a P-gp expression, we performed an anti-P-gp
immunohistochemistry using C494 antibodies (which
recognized one intracellular epitope). Figure 6 shows
representative whole-mount MTS labels with anti-P-gp
antibody. Positivity to P-gp was evident in all cells form-
ing the INER-37 MTS. For INER-51, no differences in
immunochemical label to P-gp were observed between
monolayers and MTS (data not shown).Discussion
By using a low adhesion model to produce multicellular
tumour spheroids, we were able to generate reproducible-
sized spheroids of two lung cancer cell lines. Each MTS
showed its own characteristics in growth and shape,
with spheroids reaching up to 500 μm in diameter.Several studies show that the acquisition of drug re-
sistance in MTS is mainly due to low penetration, a
phenomenon that becomes more evident in spheroids
up to 400 μm [15,16]. The INER-37 MTS were formed
by tightly attached cells, resembling a classical model de-
scribed for others spheroids, where cellular aggregation
as well as the presence of tortuous 3-D scaffold struc-
tures may limit the drug exposure to some cells and
could be in part responsible for chemoresistance [17]. In
contrast, in INER-51 MTS, the peripheral zone was
formed by a narrow multicellular layer rim with multiple
intercellular spaces, allowing the free diffusion of drugs
toward the centre of the spherule. Thus, a limited drug
diffusion associated with large spherule size is difficult
to consider both MTS models because of the tissue ar-
rangement observed in INER-51 spheroids. Differences
in the penetration rate for anticancer agents as a func-
tion of cellular adhesion and packing density were
shown by Grantab et al. in a model of multicellular
layers using two epithelioid and round subclones of
HCT-8 colon carcinoma cell line [18]. In addition, the
morphological observation and the evidence that 14C-
doxorubicin penetration through multicellular layers
show a free drug transit without any multicellular inter-
ference [19,20], as well as spheroid permeability data ob-
tained for various drugs including doxorubicin [12],
suggest to us that impaired penetration of anticancer
agents through MTS is not a general phenomenon to
explain MCR, as has been mentioned before.
The spherule formation also resulted in different depth-
dependent micro-environmental conditions, such as gra-
dient of oxygen and pH [21], nutrients [22], and accumu-
lation of catabolic products in the centre of the spheroid
[23], which produce differential cell nutrition based on
cell´s localization and the appearance of quiescent cells.
Under these conditions, smaller spheroids consist exclu-
sively of proliferating cellular-cycling cells, while larger
spheroids contain extended areas of quiescent cells
arrested in the G0/G1 phase of the cell cycle. It is com-
monly known that quiescent cells are relatively resistant
toward anti-cancer drugs and this has been explained
mainly by a reduced susceptibility of DNA damage [24]
or increasing capability of DNA repair [25]. In our case,
both INER-37 and INER-51 MTS showed a decrease in
the cell proliferation, with a proportional rise of cell
population in G0/G1 phase that could be responsible for
MCR. Interestingly, host cell microenvironment or cell-
cell interactions seem to be greatly important in MCR
generation, as both lung cell lines arrested by serum
deprivation showed only a discrete increase in resistance
to etoposide (data not shown).
Furthermore, much evidence shows that multidrug
resistance is associated with the expression of multi-
drug related genes [26,27], especially in the up-regulated
Figure 3 Cell cycle analysis of lung cancer cell lines grown as monolayer or MTS. Cell lines INER-37 or INER-51 as monolayer (A, C) or MTS (B, D)
respectively, were disassociated with 0.25% trypsin, washed, and stained with propidium iodide for DNA content analysis as described in Material
and methods. Flow cytometry was then used to generate cell cycle profiles. Each flow cytometry plot depict the mean percentage of G1 (2n),
S and G2/M (4n) fraction population. Each value represents the mean of at least two experiments.
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cific sets of genes has been shown to be modulated by
cell culture architecture [29], possibly in relation to sig-
nals effectively transduced upon interaction of adhesion
molecules with their counter receptors [30]. In our case,
lung cancer MTS showed significant changes in tran-
script production of several of these MDR related genes.
Thus, INER-37 MTS turned on MDR-1 gene and its
product, P-gp, helped us understand the increase in
drug resistance. Therefore, drug resistance of INER-37
MTS could be matched with a more classic mechanism,
where the quiescent state is closely related to the ex-
pression of P-gp, constituting the first line barrier to ob-
struct drug from diffusing the centre of the spherule.
Increased P-gp expression and MDR phenotype in the
absence of any previous exposure to chemotherapy
drugs have been found in monolayers cultured underconditions that mimic the micro-environment present
in quiescent cells layers of MTS i.e. confluence [31],
hypoxia [32], glucose deprivation [33] and increased
hydrostatic pressure and acidic pH [34]. Conversely, in
INER-51 MTS neither up-regulated MDR-1 nor expres-
sion of MRP-1/GST-μ transcripts was observed. In a
previous work, we found that INER-51 MTS showed a
more efficient P-gp activity, which was responsible of
maintaining lower retention levels of doxorubicin.
However, P-gp expression contributes to keeps lower
levels of doxorubicin in the MTS; the mechanisms that
govern the MCR seems to be different because the lack
of P-gp-expression only showed a minor impact of re-
sistance to several chemotherapy drugs, suggesting that
other non-P-gp mechanisms are also operating [35]. In
addition, constitutive expression of BCRP1 has been
identified in INER-51 cells; however this mechanism per
Figure 4 (See legend on next page.)
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Figure 4 Dose–response curves to cytotoxic agents of lung cancer cell lines grown as monolayer or spheroids. Cell lines INER-37 or INER-51 as
monolayer (●) or MTS (○) were exposed to varying concentrations of etoposide, teniposide, doxorubicin or camptothecin, for 72 h. Drug
cytotoxicity was determined by incubation with the tetrazolium dye MTT and measurement of absorbance at 540 nm. Each point value is the
average of six independent experiments.
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the broad spectra of chemotherapeutic agents studied.
The degree of tumour responsiveness to different che-
motherapeutic drugs has also been associated to the
relative level of expression of Topo IIα and Topo IIβ iso-
forms. Reduction of transcription of topo II to one third
of the initial activity, occurs within 1 day of growth as
spheroids, and declines by a similar proportion again
over 3–4 days [36]. Our results show that INER-37 MTS
did not modify the transcription levels of Topo IIα, as it
was expressed to the same extent in both culture types.
However, in previous studies we reported that INER-37
cells have a mutation in the Topo IIα gene, which en-
codes for a cytoplasmic enzyme [37]. In agreement with
our results, Oloumi et al. found that etoposide resistance
correlated with changes in subcellular distribution of
Topo IIα in outer cells of V79 spheroids and xenograft
tumors [38]. Thus, in INER-37 MTS, the multicellular
resistance seems to be the result of a combination of
mechanisms: through expression of P-gp pump and by
an altered intracellular distribution of the Topo IIα en-
zyme. In INER-51 MTS, the results were different, since
Topo IIα seems to be down regulated. For these cells,
the low expression of the Topo IIα gene and the activity
of P-gp could explain the resistance to Topo II inhibitors
(like doxorubicin, etoposide and teniposide).
Unlike Topo IIα, most evidence has shown that the
transcription of Topo IIβ is not cell cycle regulated [39].
However, the transcript of Topo IIβ was up-regulated in
the two types of MTS, suggesting some dependency on
the cell cycle. Our results are similar to those of Drake
et al., who found an increase in the levels of Topo IIβTable 1 IC50 mean values for different drugs tested in monola
Drug INER-37 2D (μM). INER-37 MTS (μM). t
Etoposide 17.9 >500 0
Teniposide 9.5 >500 0
Doxorubicin 3.9 >100 <
Camptothecin 9.1 >100 0
5-Fluorouracil 300 >500 N
Methotrexate 300 >500 N
Cytosine-Arabinoside 300 >500 N
Cisplatin 29.0 74.8 0
Five thousand cells per well were plated in 96 well plate previously precoated with
Each IC50 value is the average of six independent experiments. The symbol (>) indic
NS: Not significant.and a decrease in Topo IIα, both associated with a state
of quiescence [40].
Several other mechanisms of drug resistance seem to
be intimately related to the three dimensional cell
growth. One of them is the interaction between MRP-1
and GST enzymes [41]. The GST enzymes can chem-
ically alter several types of drugs that will serve as sub-
strates for MRP-1 that contribute to extrude them out of
the cell [42]. In INER-37 MTS, the up-regulated expres-
sion of MRP-1 working with GST-μ could be important
in drug resistance to doxorubicin. Interestingly, in INER-
51 MTS these were not the mechanisms employed be-
cause non of these genes was expressed. However, as we
do not know much about the possible interaction of these
two systems and considering the fact that we only studied
one member of the GST family, it is reasonable to believe
that other members of the GST family might interact with
other members of the MRP family members to induce
MCR [43]. Takagi et al. found that the gene expression
profile in the MTS was different from that in the mono-
layers; however, it was similar to that in the solid tumor
tissue [44].
Conclusion
The culture of lung cancer lines as MTS results in the
acquisition of MCR mechanisms which confer adaptive
advantages of the multicellular growth given by micro-
environmental conditions. Many of them are inter-
related or independent of each other, but may exist sim-
ultaneously in cancer cells or subpopulation of cells,
producing an overall drug-resistant phenotype. Conse-
quently, each cell line seems to implement differentyer and MTS of lung cancer cell lines
-student INER-51 2D (μM). INER-51 MTS (μM). t-student
.0001 9.9 >500 <0.0001
.0003 3.9 >500 <0.0001
0.0001 7.9 87.3 0.014
.004 0.01 >100 <0.0001
S 5.0 >500 <0.0001
S 2.6 >500 <0.0001
S 0.95 >500 <0.0001
,033 74.8 25.5 0,003
or without agarose and the drug cytotoxicity was determinate by MTT assay.
ates that the IC50 was not reached at the highest concentration tested.
Figure 5 Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of mRNA expression for MDR-related gene products on lung cancer
cell lines grown as monolayers or MTS. The expression of the following genes was evaluated: MDR-1, MRP-1, Topo IIα, Topo IIβ, GST-μ, Topo I, and
G3PDH. Amplification products were electrophoretically separated in polyacrylamide gels and revealed by etidium bromure staining. The analysis
of G3PDH expression was used as constitutive control for the integrity of RNA molecules. A) Representative RT-PCR and B) Densitometric analysis
of RT-PCR band intensities for MDR-related genes normalized by G3PDH. Data are mean ± standard deviation (SD) of three independent experiments.
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fining the mechanisms that regulate drug-resistant
phenotype in vitro may provide key information for the
development of novel treatment strategies to overcome
drug resistance.Material and methods
Chemicals
Etoposide (VP-16), teniposide (VM-26), 5-Fluorouracil
(5-FU), doxorubicin hydrochloride (DXR), cytosine β-
D-arabinofuranoside (Ara-C), methotrexate hydrate (MTX),
cyclophosphamide monohydrate), Cisplatin and (S)-(+)-
Camptothecin (CPT), 3-[4,5-Dimethyl-thizol-2-yl]-2,5-di-
phenyltetrazolium bromide (MTT) were pursed from
Sigma-Aldrich Co., St. Louis MO. Drugs were dissolved
in dimethyl sulfoxide to 100 mM stock solutions that
were stored at 4°C. These were diluted in water to
1 mM working stocks prior to the assays.Lung cancer cell lines
In this study we used two cancer cell lines designated as
INER-37 and INER-51. Both tumour cell lines were estab-
lished in our laboratory from plural effusions of patients
with primary lung cancer without previous chemotherapy
treatment. Pleural effusion samples were collected afterobtaining written and signed informed consent, in ac-
cordance with the Helsinki Declaration.
By cytological studies, INER-37 tumour cells were
identified as a well-differentiated adenocarcinoma while
INER-51 tumour cells were characterized as a poorly dif-
ferentiated adenocarcinoma.
The EGFR-mutation status in exons 18, 19, 20 and 21
of the EGFR gene was negative for both cell lines.Culture of monolayers and MTS
The lung cancer cell lines INER-51 and INER-37 were
grown as monolayer cultures in RPMI-1640 medium
at 37°C in 5% CO2. The medium was supplemented
with 10% fetal calf serum (Thermo Scientific*HyClone),
2 mM L-glutamine, 100 units/ml of penicillin and
100 μg/ml of streptomycin. On reaching 75% confluency,
the tumour cells were washed with phosphate-buffered
saline (PBS) and then removed from the flask by the
addition of 0.25% trypsin (Invitrogen™, Life Technologies)
and washed twice with PBS. To obtain MTS, approxi-
mately 5–7 × 103 cells/well were seeded onto 1%
agarose-coated 24-well/plate with RPMI-1640 complete
medium. Three-dimensional cell cultures were routinely
grown for 72 hours to acquire MTS larger than 500 μm
of diameter. For cell proliferation, both monolayers and
MTS growths were determined by MTT essay.
Figure 6 Immunocytochemistry of INER-37 cells. A) Monolayer cells
or B) multicellular tumour spheroids of INER-37 were labelled with
anti-P-gp (C494 antibody, DAKO) and immunostained with anti-
rabbit IgG linked to biotin-HRP, followed by DBA to develop colour.
Photomicrographs were taken with a Nikon microscope at 620X of
total magnification.
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Tumour spheroids were examined cytologically via rou-
tine paraffin slicing techniques after fixation on absolute
ethanol. The thickness of the hematoxylin-eosin stained
serially sliced paraffin section was of 5 μm. For im-
munological analysis, monolayer of cells (grown on
microscope slides) and multicellular tissue samples were
reacted with antibody anti-P-gp (C494 antibody, Dako
Inc.) at a dilution of 1:50.
Detection of primary antibody was done with a detec-
tion system kit (VECTASTAIN® ABC systems) with a sec-
ondary goat anti-mouse immunoglobulin-G linked to
biotin-HRP, followed by DBA to develop colour.
Scanning electron microscopy (SEM)
Multicellular spheroids were washed with PBS and fixed
in 2.5% glutaraldehyde for 2 h. The spherules were then
post-fixed on the plate with 1% OsO4 in 0.1 M cacody-
late buffer pH 7.3 before dehydrating with ethanol, critical
point drying, mounting on carbon stubs, and coating with
gold before viewing under a JEOL 7401 series FEGSEM
(Jeol Ltd).Drug resistance in monolayers or MTS
The level of resistance to drugs was determined with the
use of the MTT assay as previously described [35]. For
monolayers, 7 × 103 cells/well were plated in 96-well/
plate (Costar, USA) and drugs were added at different
concentrations per well. In the case of the MTS, they
were obtained as described above and were fed with
fresh complete medium containing different drug con-
centrations. After 72 hours, the culture medium was re-
moved and MTT reagent diluted in PBS was added to
obtain a final concentration of 2 mg/ml. After incuba-
tion for 4 hours, individual spheroids surrounded with
formazan crystals were transferred into 1.5 ml eppendorf
tubes. Cells in monolayers were washed carefully with
PBS once. Both monolayers and MTS crystals were dis-
solved by addition of 100% DMSO for 20 min with
occasional shaking. Absorbance at 540 nm was mea-
sured using an automated microplate reader (Labsystem
Multiskan MS, Finland). In each experiment, the drug de-
termination was analyzed in six individual wells. Cell sur-
vival was estimated as a percentage of the corresponding
control. Drug-cytotoxicity was assayed by the IC50, corre-
sponding to the 50% decrease in cell survival rate com-
pared to the no-drug treated cultures.In vitro reverse transcriptase-PCR assay
Total RNA was extracted from the cell lines with Trizol
reagent (Invitrogen™, USA) according to the manufactur-
er's instructions. Single stranded cDNA was synthesized
by reverse transcription from 5 μg of total RNA using
Superscript™ RNAse Reverse Transcriptase (Invitrogen™,
USA) and oligo-dT16–18. The amplification was per-
formed in a final volume of 25 μl, containing 0.5 μl
cDNA, 50 pM of each oligonucleotide primer, 30 μM of
each dNTPs, 2.5 units of Taq DNA polymerase, 1.5 mM
MgCl2, 20 mM Tris–HCl (pH 8.4) and 50 mM KCl.
Amplification was carried out in a Thermal Cycler
(Programmed Thermal Controller, model PTC-100, MJ
Research Inc., USA) for 35 cycles of denaturalisation at
94°C for 1 min, annealing at 55–60°C for 2 min, and
polymerising at 72°C for 3 min. The PCR primers and
expected product size were as follows: For MDR-1, for-
ward: 5'-cccatcattgcaatagcagg-3' and reverse: 5'-gttc
aaacttctgctcctga-3 [150 bp]; MRP1, forward: 5'-tctctcc
cgacatgaccgagg-3' and reverse: 5'-ccaggaatatgatgccccga
cttc-3' [140 bp]; topoisomerase IIα, forward: 5'-tttaag
gcccaagtccagttaaac-3' and reverse: 5'-gtataacaatatcatca
agattgt [343 bp]; topoisomerase IIβ, forward: 5'-ga
agtgttcactagtaaaatacagt-3' and reverse: 5'-cataatctttccat
agcgtaaggtt-3' [336 bp]; topoisomerase I, forward: 5'-aa
gcagaggaagtagctacg-3' and reverse: 5'-gctcatctgtttccga
gctt-3' [206 bp]; GST-μ, forward: 5'-gaactccctgaaaagcta
aag-3' and reverse: 5'-gttgggctcaaatatacggtgg-3' [250 bp];
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5'-gaaggggtcattgatggcaa-3' [110 bp].
Cell cycle analysis
Tumour cells were fixed in ethanol 80% at −20°C. Sam-
ples were rehydrated in two steps to 100% water.
Tumour cells were digested by pepsin (5 mg/ml) in 0.9%
saline solution, pH 1.5, at 37°C for 20 min. Samples were
washed with PBS and 1 × 106 cell nuclei were incubated
with trypsin (30 μg/ml) for 10 min. Immediately, soy-
bean trypsin inhibitor (277 μg/ml) and ribonuclease
(55 μg/ml) were added and incubated for additional
10 min at room temperature. Finally, propidium iodide
(150 μg/ml) was added to the nuclear preparation and
incubated in darkness at 4°C for 10 min. Nuclei were
analysed in a FacSort flow cytometer with argon laser
adjusted to emit light at 488 nm. Histograms of the area
under the curve of FL2 (FL2 H) were obtained. Data
analysis was performed with ModFit software using
RFIT mathematical model (Becton-Dickenson). Calf thy-
mus and chicken erythrocyte nuclei were used as exter-
nal standards in order to validate DNA measurements in
diploid cells.
Statistical analysis
Statistical analyses were performed using Student’s t test.
The differences were considered significant for p values
of <0.05.
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